EpiVax, Zoetis

EpiVax Inc. Zoetis Illinois Rhode Island

10.01.2023 - 14:03:11

EpiVax and Zoetis to Collaborate on Swine T cell Epitope Prediction Tool: CircoMatch™

CircoMatch results in a quick turnaround, powerful way for Zoetis to provide veterinarians and producers with predictive effectiveness data so they can make informed decisions about their vaccination programs.   

Zoetis and EpiVax will be sharing more details on this new collaboration during the upcoming Conference of Research Workers in Animal Diseases (CRWAD) meeting in Chicago, January 22-24, 2023.

About EpiVax:

EpiVax is a biotechnology company with expertise in T cell epitope prediction and rapid vaccine design. EpiVax's immunogenicity screening toolkits for therapeutics and vaccines are employed in advancing the research of a global roster of companies. For more information, visit www.epivax.com.

About Zoetis:

As the world's leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70 years innovating ways to predict, prevent, detect, and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide -- from livestock farmers to veterinarians and pet owners. The company's leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. For more information, visit www.zoetis.com.

Press Contact:
Katie Porter, Associate Director, Business Development & Marketing
EpiVax
kporter@epivax.com

Logo - https://mma.prnewswire.com/media/542055/EpiVax_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/epivax-and-zoetis-to-collaborate-on-swine-t-cell-epitope-prediction-tool-circomatch-301715657.html

@ prnewswire.co.uk